ARCHIVES

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

House Committee Gives NCI Only $6.5 Million Over President’s request

July 28, 1989

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986

House Bill Gives NCI $135 Million Increase, NIH $846 Million for FY 1988 Over 1987 Budgets

August 7, 1987

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

NCI To Lose 382 Cancer FTEs; DCE Board Gets Response From Sullivan, But No Promises

July 21, 1989

Genentech’s Ferrara Selected for GM Award.

June 23, 2006